National Health Investors Inc. (NYSE:NHI) hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $78.23 and last traded at $78.06, with a volume of 101,958 shares. The stock had previously closed at $76.68.

A number of equities research analysts have issued reports on NHI shares. Zacks Investment Research upgraded shares of National Health Investors from a “hold” rating to a “buy” rating and set a $77.00 price objective on the stock in a research note on Wednesday, April 27th. Cantor Fitzgerald started coverage on shares of National Health Investors in a research note on Thursday, June 23rd. They set a “hold” rating and a $70.00 price objective on the stock. Finally, JMP Securities reiterated a “hold” rating on shares of National Health Investors in a research note on Saturday, June 4th. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $70.17.

The company has a market cap of $3.02 billion and a P/E ratio of 19.61. The firm’s 50 day moving average price is $74.88 and its 200-day moving average price is $67.46.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Friday, May 6th. The real estate investment trust reported $1.16 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.17 by $0.01. The company had revenue of $59.02 million for the quarter, compared to the consensus estimate of $57.81 million. The business’s revenue was up 5.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.13 earnings per share. Analysts anticipate that National Health Investors Inc. will post $4.87 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 10th. Investors of record on Thursday, June 30th will be paid a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 4.58%. The ex-dividend date of this dividend is Tuesday, June 28th.

In related news, insider Kristin Sallee Gaines sold 8,652 shares of the business’s stock in a transaction dated Wednesday, June 29th. The stock was sold at an average price of $73.98, for a total value of $640,074.96. Following the sale, the insider now directly owns 53,089 shares in the company, valued at approximately $3,927,524.22. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Robert A. Mccabe, Jr. sold 1,250 shares of the business’s stock in a transaction dated Monday, June 13th. The shares were sold at an average price of $71.61, for a total value of $89,512.50. Following the completion of the sale, the director now owns 9,736 shares in the company, valued at $697,194.96. The disclosure for this sale can be found here.

A number of large investors have recently made changes to their positions in NHI. New York State Common Retirement Fund boosted its stake in shares of National Health Investors by 2.9% in the fourth quarter. New York State Common Retirement Fund now owns 35,300 shares of the real estate investment trust’s stock valued at $2,149,000 after buying an additional 1,000 shares in the last quarter. Advantus Capital Management Inc boosted its stake in shares of National Health Investors by 3.7% in the fourth quarter. Advantus Capital Management Inc now owns 50,606 shares of the real estate investment trust’s stock valued at $3,080,000 after buying an additional 1,800 shares in the last quarter. Rhumbline Advisers boosted its stake in shares of National Health Investors by 2.2% in the fourth quarter. Rhumbline Advisers now owns 62,343 shares of the real estate investment trust’s stock valued at $3,795,000 after buying an additional 1,320 shares in the last quarter. Schroder Investment Management Group bought a new stake in shares of National Health Investors during the fourth quarter valued at $4,973,000. Finally, Westfield Capital Management Co. LP boosted its stake in shares of National Health Investors by 81.4% in the fourth quarter. Westfield Capital Management Co. LP now owns 436,425 shares of the real estate investment trust’s stock valued at $26,565,000 after buying an additional 195,807 shares in the last quarter.

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.